You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

nonconforming lisocabtagene mareleucel

Showing 1 - 15 of 15
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Refractory Aggressive B-cell Lymphomas, Refractory B-Cell Non-Hodgkin Lymphoma, Aggressive B-cell NHL Trial in Boston

Not yet recruiting
  • Refractory Aggressive B-cell Lymphomas
  • +12 more
  • Boston, Massachusetts
  • +1 more
Oct 13, 2022

Primary Mediastinal Large B-cell Lymphoma (PMBCL), Primary Mediastinal Large B Cell Lymphoma, Primary Mediastinal Large B-Cell

Not yet recruiting
  • Primary Mediastinal Large B-cell Lymphoma (PMBCL)
  • +5 more
  • Boston, Massachusetts
  • +1 more
Jun 28, 2023

Recurrent DLBCL, Recurrent DLBCL, Not Otherwise Specified, Recurrent Grade 3b Follicular Lymphoma Trial in Seattle

Recruiting
  • Recurrent Diffuse Large B-Cell Lymphoma
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 30, 2022

Lymphoma, Non-Hodgkin, Lymphoma, Nonhodgkin, Lymphoma, B-Cell Trial in United States (lisocabtagene maraleucel)

Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • +3 more
  • lisocabtagene maraleucel
  • Gilbert, Arizona
  • +40 more
Apr 22, 2022

Cancer, Relapsed/Refractory Large B-cell Lymphoma (LBCL) Trial (Fludarabine (30 mg/m^2), Cyclophosphamide (500 mg/m^2), CRG-022

Not yet recruiting
  • Cancer
  • Relapsed/Refractory Large B-cell Lymphoma (LBCL)
  • Fludarabine (30 mg/m^2)
  • +2 more
  • (no location specified)
Jul 25, 2023

Recurrent Transformed Chronic Lymphocytic Leukemia, Refractory Transformed Chronic Lymphocytic Leukemia, Transformed Chronic

Not yet recruiting
  • Recurrent Transformed Chronic Lymphocytic Leukemia
  • +7 more
  • Biospecimen Collection
  • +9 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
May 15, 2023

Multiple Myeloma Trial (Nonconforming idecabtagene vicleucel)

Available
  • Multiple Myeloma
  • Nonconforming idecabtagene vicleucel
  • (no location specified)
Feb 7, 2022

Fertility Desires and Reproductive Needs of Transgender People

Completed
  • Fertility Preservation
  • +2 more
  • No intervention
  • Vandoeuvre Les Nancy, France
    University Hospital of Nancy
Feb 8, 2022

Recurrent Transformed Chronic Lymphocytic Leukemia, Refractory Transformed Chronic Lymphocytic Leukemia, Richter Syndrome Trial

Not yet recruiting
  • Recurrent Transformed Chronic Lymphocytic Leukemia
  • +2 more
  • Biopsy
  • +10 more
  • Duarte, California
    City of Hope Medical Center
Jan 3, 2023

Lymphoma, Non-Hodgkin Trial in Worldwide (Standard of Care, JCAR017)

Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • Standard of Care
  • JCAR017
  • Phoenix, Arizona
  • +78 more
Jan 13, 2023

DLBCL, Grade 3b Follicular Lymphoma, Primary Mediastinal (Thymic) Large B-Cell Lymphoma Trial (biological, procedure, drug,

Not yet recruiting
  • Diffuse Large B-Cell Lymphoma
  • +6 more
  • Axicabtagene Ciloleucel
  • +10 more
  • (no location specified)
Jan 13, 2023

Gender Affirming Communication Skills Trial in Columbia, Towson (Computer based role play trianing)

Recruiting
  • Gender Affirming Communication Skills
  • Computer based role play trianing
  • Columbia, Maryland
  • +1 more
Mar 25, 2021

Gender Incongruence, Gender Dysphoria Trial in Xiamen (Hormone Overdose and Misuse)

Not yet recruiting
  • Gender Incongruence
  • Gender Dysphoria
  • Hormone Overdose and Misuse
  • Xiamen, Fujian, China
    School of Medicine, Xiamen University
Oct 14, 2022

Gender Identity Trial (TGNC Directed Advocacy Meetings)

Unknown status
  • Gender Identity
  • TGNC Directed Advocacy Meetings
  • (no location specified)
Jan 15, 2019

Functional Performance, Synthetic Male Condom Trial in Kuching ((1) WONDALEAF-CAP, (2) WONDALEAF-ON-MEN, (3) durex-TOGETHER

Completed
  • Functional Performance
  • Synthetic Male Condom
  • (1) WONDALEAF-CAP, (2) WONDALEAF-ON-MEN, (3) durex-TOGETHER (active comparator)
  • Kuching, Sarawak, Malaysia
  • +1 more
Jul 16, 2018